Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aerie Pharmaceuticals Q3 EPS $(0.27) Up From $(0.72) YoY, Sales $36.13M Up From $29.31M YoY

Author: Benzinga Newsdesk | November 03, 2022 05:07pm
Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.27) per share. This is a 62.5 percent increase over losses of $(0.72) per share from the same period last year. The company reported $36.13 million in sales this quarter. This is a 23.25 percent increase over sales of $29.31 million the same period last year.

Posted In: AERI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist